These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15040160)

  • 1. [Dyslipidemia and the metabolic syndrome].
    Soska V
    Vnitr Lek; 2003 Dec; 49(12):943-7. PubMed ID: 15040160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus.
    Brunzell JD; Ayyobi AF
    Am J Med; 2003 Dec; 115 Suppl 8A():24S-28S. PubMed ID: 14678862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and management of the dyslipidemia of the metabolic syndrome.
    Raal FJ
    Metab Syndr Relat Disord; 2009 Apr; 7(2):83-8. PubMed ID: 19400742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypolipidemic therapy for the metabolic syndrome.
    Cignarella A; Bellosta S; Corsini A; Bolego C
    Pharmacol Res; 2006 Jun; 53(6):492-500. PubMed ID: 16621589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipid comparison in patients treated by statins or fibrates: existence of bad HDL-C responders to statins.
    Devroey D; Velkeniers B; Duquet W; Betz W
    Acta Cardiol; 2003 Jun; 58(3):179-84. PubMed ID: 12846506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetic dyslipidemia: which target levels and treatment options exist for diabetics?].
    Broedl UC; Lehrke M; Parhofer KG
    MMW Fortschr Med; 2008 Jun; 150(25):41-3. PubMed ID: 18705054
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolic syndrome and hyperlipidemia in HIV-positive patients].
    Behrens GM
    Herz; 2005 Sep; 30(6):458-66. PubMed ID: 16170675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic syndrome: pathophysiology, clinical relevance, and use of niacin.
    Ito MK
    Ann Pharmacother; 2004 Feb; 38(2):277-85. PubMed ID: 14742767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of diabetic dyslipoproteinemia.
    Steinmetz A
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):239-45. PubMed ID: 12951627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and treatment of lipid disorders in women.
    Zelis R
    Curr Womens Health Rep; 2003 Apr; 3(2):97-103. PubMed ID: 12628078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic abnormalities: high-density lipoproteins.
    Barter P
    Endocrinol Metab Clin North Am; 2004 Jun; 33(2):393-403. PubMed ID: 15158525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dyslipidemia in metabolic syndrome].
    Ikewaki K; Tohyama J
    Nihon Rinsho; 2004 Jun; 62(6):1099-103. PubMed ID: 15206147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients.
    Soran H; France MW; Kwok S; Dissanayake S; Charlton-Menys V; Younis NN; Durrington PN
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):566-71. PubMed ID: 22006975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.